当前位置:
X-MOL 学术
›
Cancer Discov.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Neoantigen Quality Predicts Immune Response, Survival
Cancer Discovery ( IF 28.2 ) Pub Date : 2018-01-01 , DOI: 10.1158/2159-8290.cd-nb2017-165 American Association for Cancer Research
中文翻译:
新抗原质量可预测免疫反应,存活率
更新日期:2018-01-08
Cancer Discovery ( IF 28.2 ) Pub Date : 2018-01-01 , DOI: 10.1158/2159-8290.cd-nb2017-165 American Association for Cancer Research
A new mathematical model finds that tumor neoantigen quality trumps quantity when it comes to predicting response to immunotherapy and the likelihood of long-term survival among patients with cancer.
中文翻译:
新抗原质量可预测免疫反应,存活率
一种新的数学模型发现,在预测对免疫疗法的反应以及癌症患者中长期存活的可能性时,肿瘤新抗原的质量胜过数量。